NCT06732830View on ClinicalTrials.gov

Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

September 25, 2023

Study Completion Date

September 25, 2023

Conditions
Dry Eye Syndrome
Interventions
DEVICE

DayDrop Advanced ophthalmic drop

The patient will administer 1 or 2 drops of DayDrop Advanced in each eye 3 times a day for 3 months.

Trial Locations (1)

01009

Hospital Universitario Araba, Vitoria-Gasteiz

Sponsors
All Listed Sponsors
collaborator

Bioaraba Health Research Institute

NETWORK

lead

i+Med S.Coop.

INDUSTRY